TY - JOUR
T1 - Clinical-biochemical correlation in molecularly characterized patients with Niemann-Pick type C
AU - Meiner, Vardiella
AU - Shpitzen, Shoshi
AU - Mandel, Hanna
AU - Klar, Aharon
AU - Ben-Neriah, Ziva
AU - Zlotogora, Jol
AU - Sagi, Michal
AU - Lossos, Alex
AU - Bargal, Ruth
AU - Sury, Vivy
AU - Carmi, Rivka
AU - Leitersdorf, Eran
AU - Zeigler, Marsha
PY - 2001/1/1
Y1 - 2001/1/1
N2 - Purpose: Niemann-Pick disease type C (NP-C) is an autosomal recessive lipid storage disease manifested by an impairment in cellular cholesterol homeostasis. The clinical phenotype of NP-C is extremely variable, ranging from an acute neonatal form to an adult late-onset presentation. To facilitate phenotype-genotype studies, we have analyzed multiple Israeli NP-C families. Methods: The severity of the disease was assessed by the age at onset, hepatic involvement, neurological deterioration, and cholesterol esterification studies. Screening of the entire NPC1 coding sequence allowed for molecular characterization and identification of disease causing mutations. Results: A total of nine NP-C index cases with mainly neurovisceral involvement were characterized. We demonstrated a possible link between the severity of the clinical phenotype and the cholesterol esterification levels in fibroblast cultures following 24 hours of in vitro cholesterol loading. In addition, we identified eight novel mutations in the NPC1 gene. Conclusions: Our results further support the clinical and allelic heterogeneity of NP-C and point to possible association between the clinical and the biochemical phenotype in distinct affected Israeli families.
AB - Purpose: Niemann-Pick disease type C (NP-C) is an autosomal recessive lipid storage disease manifested by an impairment in cellular cholesterol homeostasis. The clinical phenotype of NP-C is extremely variable, ranging from an acute neonatal form to an adult late-onset presentation. To facilitate phenotype-genotype studies, we have analyzed multiple Israeli NP-C families. Methods: The severity of the disease was assessed by the age at onset, hepatic involvement, neurological deterioration, and cholesterol esterification studies. Screening of the entire NPC1 coding sequence allowed for molecular characterization and identification of disease causing mutations. Results: A total of nine NP-C index cases with mainly neurovisceral involvement were characterized. We demonstrated a possible link between the severity of the clinical phenotype and the cholesterol esterification levels in fibroblast cultures following 24 hours of in vitro cholesterol loading. In addition, we identified eight novel mutations in the NPC1 gene. Conclusions: Our results further support the clinical and allelic heterogeneity of NP-C and point to possible association between the clinical and the biochemical phenotype in distinct affected Israeli families.
KW - Cholesterol esterification
KW - Consanguineous marriage
KW - Lipid storage disease
KW - Mutation analyses
KW - NPC1 gene
UR - http://www.scopus.com/inward/record.url?scp=18544363771&partnerID=8YFLogxK
U2 - 10.1097/00125817-200109000-00003
DO - 10.1097/00125817-200109000-00003
M3 - Article
C2 - 11545687
AN - SCOPUS:18544363771
SN - 1098-3600
VL - 3
SP - 343
EP - 348
JO - Genetics in Medicine
JF - Genetics in Medicine
IS - 5
ER -